As the AR has been reported to repress both PCa tumor suppressor genes [4–7] and oncogenes [8–10], a deeper understanding of AR-mediated suppression will be vital to the development of future therapeutics which prevent the emergence of CRPC. The gene discussed is AR; the disease is posterior cortical atrophy.